Skip to content

iRhythm Holdings, Inc. IRTC Investments - Amortized Cost Basis

Investments - Amortized Cost Basis at other companies

Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
Edwards Lifesciences logo
Edwards LifesciencesEW
ResMed logo
ResMedRMD

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.62B+16.0%

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's investments - amortized cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's investments - amortized cost basis?
iRhythm Holdings, Inc. (IRTC) reported investments - amortized cost basis of $455.35M in Q1 2026.
How has iRhythm Holdings, Inc. 's investments - amortized cost basis changed year-over-year?
iRhythm Holdings, Inc. 's investments - amortized cost basis increased by 42.2% year-over-year, from $320.21M to $455.35M.
What is the long-term trend for iRhythm Holdings, Inc. 's investments - amortized cost basis?
Over 5 years (2020 to 2025), iRhythm Holdings, Inc. 's investments - amortized cost basis has grown at a 9.8% compound annual growth rate (CAGR), from $306.4M to $489.89M.